Biolife Solutions (BLFS) Non-Current Assets (2010 - 2026)
Biolife Solutions' (BLFS) quarterly Non-Current Assets came in at $267.7 million in Q1 2026, up 1.39% year-on-year from $264.0 million in Q1 2025, and down 0.61% on a QoQ basis from $269.3 million in Q4 2025.
Biolife Solutions (BLFS) Non-Current Assets (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has 17 years of Non-Current Assets data on file, last reported at $267.7 million in Q1 2026.
- On a quarterly basis, Non-Current Assets rose 1.39% year-over-year to $267.7 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 2.69% decrease from a year earlier, with the FY2025 full-year figure at $269.3 million, up 7.42% from the prior year.
- Non-Current Assets for Q1 2026 stood at $267.7 million, down from $269.3 million in the prior quarter.
- Over the last five years, Non-Current Assets for BLFS reached as high as $425.3 million in Q1 2022 and fell as low as $250.7 million in Q4 2024.
- Historically, Non-Current Assets has averaged $300.1 million across 5 years, with a median of $292.1 million in 2023.
- On a YoY basis, Non-Current Assets climbed as much as 244.43% in 2022 and fell as far as 27.19% in 2022.
- Year by year, Non-Current Assets stood at $311.8 million in 2022, then dropped by 6.31% to $292.1 million in 2023, then decreased by 14.17% to $250.7 million in 2024, then advanced by 7.42% to $269.3 million in 2025, then retreated by 0.61% to $267.7 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $267.7 million in Q1 2026, $269.3 million in Q4 2025, and $265.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Biolife Solutions | 1.50 Bn | 1.42 Bn | 17.50 Mn | 267.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 267.68 Mn |
| Dec 31, 2025 | 269.32 Mn |
| Sep 30, 2025 | 265.52 Mn |
| Jun 30, 2025 | 261.81 Mn |
| Mar 31, 2025 | 264.01 Mn |
| Dec 31, 2024 | 250.73 Mn |
| Sep 30, 2024 | 292.27 Mn |
| Jun 30, 2024 | 286.78 Mn |
| Mar 31, 2024 | 289.90 Mn |
| Dec 31, 2023 | 292.11 Mn |
| Sep 30, 2023 | 294.33 Mn |
| Jun 30, 2023 | 312.87 Mn |
| Mar 31, 2023 | 313.68 Mn |
| Dec 31, 2022 | 311.78 Mn |
| Sep 30, 2022 | 351.81 Mn |
| Jun 30, 2022 | 352.32 Mn |
| Mar 31, 2022 | 425.31 Mn |
| Dec 31, 2021 | 428.20 Mn |
| Sep 30, 2021 | 428.89 Mn |
| Jun 30, 2021 | 393.56 Mn |